James Hartley. Aberrant Splicing Factor SF3A2 as a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay with Immune Infiltration and Natural Product Intervention. ijmsdh. 2026;12(09):176-181. doi:10.55640/ijmsdh-12-09-20